Advanced Hepatocellular Carcinoma in Adults Without Cirrhosis: A Single-Institution Retrospective Review

Advanced Hepatocellular Carcinoma in Adults Without Cirrhosis: A Single-Institution Retrospective Review

Ellery Altshuler,1 Raymond Richhart,1 Mahmoud Aryan,2 William King,1 Kelsey Pan,1 Akash Mathavan,1 Akshay Mathavan,1 Diana Rodriguez,1 Bishal Paudel,1 Nathan Northern,1 Brian Ramnaraign,3 Ilyas Sahin,3 Jesus C Fabregas3 1Department of Internal Medicine, University of Florida College of Medicine, Gai...

Full description

Bibliographic Details
Main Authors:	Altshuler E, Richhart R, Aryan M, King W, Pan K, Mathavan A, Rodriguez D, Paudel B, Northern N, Ramnaraign B, Sahin I, Fabregas, JC
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-12-01
Series:	Journal of Hepatocellular Carcinoma
Subjects:	hepatocellular carcinoma cirrhosis non-cirrhotic
Online Access:	https://www.dovepress.com/advanced-hepatocellular-carcinoma-in-adults-without-cirrhosis-a-single-peer-reviewed-fulltext-article-JHC

Similar Items

Frequency of Cardiomyopathy in Patients with Hepatic Cirrhosis
by: Mahmood Jafri, et al.
Published: (2021-12-01)

Diastolic dysfunction – negative prognostic factor in patients with hepatic cirrhosis
by: Alexandru Mihailovici, et al.
Published: (2017-06-01)

Liver Transplantation in the Treatment of Unresectable Hepatocellular Carcinoma in the Absence of Liver Cirrhosis
by: O. D. Olisov, et al.
Published: (2018-09-01)

Synchronous Hepatocellular Carcinoma and Cholangiocarcinoma in a Patient Transplanted for Cryptogenic Cirrhosis
by: B Geramizadeh, et al.
Published: (2014-07-01)

QTc prolongation and diastolic dysfunction in cirrhosis patients with higher Child-Pugh score
by: Chandrakant Salve, et al.
Published: (2023-10-01)

Effectiveness comparison of indocyanine green retention test with the cirrhotic severity scoring in evaluating the pathological severity of liver cirrhosis in patients with hepatocellular carcinoma and Child-Pugh grade A liver function
by: Jin Gu, et al.
Published: (2020-04-01)

Cirrhotic cardiomyopathy: the liver affects the heart
by: M.V.H. Carvalho, et al.
Published: (2019-02-01)

Serum Myostatin Predicts the Risk of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Multicenter Study
by: Ji Hyun Kim, et al.
Published: (2020-11-01)

A Comparative Study of Serum Angiogenic Biomarkers in Cirrhosis and Hepatocellular Carcinoma
by: Krizia Pocino, et al.
Published: (2021-12-01)

The Predictive Value of ALBI and P-ALBI Scores in The Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B and Chronic Hepatitis B+D Induced Cirrhosis
by: Tolga ŞAHİN, et al.
Published: (2019-12-01)

CHANGE OF HEART MUSCLE PERSONS WITH ALCOHOLIC LIVER
by: V. A. Porodenko, et al.
Published: (2017-07-01)

Do you have to evaluate the heart of the cirrhotic patients?
by: Mohammed Hussien Ahmed, et al.
Published: (2023-05-01)

IL-17 Genetic Variations Increase the Risk of Cirrhotic/Hepatocellular Carcinoma in Patients with Hepatitis B Virus Infection.
by: Abolfazl Gheshlaghi, et al.
Published: (2021-06-01)

Comprehensive Metabolomic Search for Biomarkers to Differentiate Early Stage Hepatocellular Carcinoma from Cirrhosis
by: Da Jung Kim, et al.
Published: (2019-10-01)

Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma
by: Yi-Te Lee, et al.
Published: (2023-04-01)

Incidence and Survival of Hepatocellular Carcinoma in Type 2 Diabetes Patients with Cirrhosis Who Were Treated with and without Metformin
by: Tangjarusritaratorn T, et al.
Published: (2021-04-01)

Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma
by: Ruipeng Zheng, et al.
Published: (2020-06-01)

A Narrative Review on Non-Cirrohotic Portal Hypertension: Not All Portal Hypertensions Mean Cirrhosis
by: Michele Fiordaliso, et al.
Published: (2023-10-01)

Influence of Hepatocellular Carcinoma on Platelet Aggregation in Cirrhosis
by: Alberto Zanetto, et al.
Published: (2021-03-01)

Investigating the Effect of Serotonin II and III Receptor Inhibitors on the Chronotropic Changes of the Heart to Isoproterenol in Rat Models of Biliary Cirrhosis
by: Sahar Asvar, et al.
Published: (2023-12-01)

Liver Cirrhosis and Hepatocellular Carcinoma Diagnosed from Chylothorax: A Case Report
by: Kenta Ito, et al.
Published: (2021-09-01)

Navigating through the Lipid Metabolism Maze: Diagnosis and Prognosis Metabolites of Hepatocellular Carcinoma versus Compensated Cirrhosis
by: Iuliana Nenu, et al.
Published: (2022-02-01)

Prognostic value of S100A4 and Glypican-3 in hepatocellular carcinoma in cirrhotic HCV patients
by: Mahmoud El-Bendary, et al.
Published: (2023-08-01)

A decision tree model to predict liver cirrhosis in hepatocellular carcinoma patients: a retrospective study
by: Zheyu Zhou, et al.
Published: (2023-08-01)

A new model predicts hepatocellular carcinoma in patients with HBV-related decompensated liver cirrhosis and long-term antiviral therapy: a prospective study
by: Hao-dan Mao, et al.
Published: (2023-03-01)

Triglyceride-Glucose Index is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients with HBV-Related Liver Cirrhosis
by: Yang SH, et al.
Published: (2024-04-01)

Approaches for Selective Vaccinations in Cirrhotic Patients
by: Giovanni Casella, et al.
Published: (2023-02-01)

The predictive value of revised diastolic dysfunction in outcomes of liver transplantation: A propensity score matching analysis
by: Shenghua Bi, et al.
Published: (2023-01-01)

Very Low Alcohol Consumption Is Associated with Lower Prevalence of Cirrhosis and Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease
by: Silvia Ferri, et al.
Published: (2022-06-01)

Comparable Overall Survival in Patients with Hepatocellular Carcinoma Diagnosed within and outside a Surveillance Programme: The Potential Impact of Liver Cirrhosis
by: Rosemary E. Faulkes, et al.
Published: (2023-02-01)

Pathway-Based Integrative Analysis of Metabolome and Microbiome Data from Hepatocellular Carcinoma and Liver Cirrhosis Patients
by: Boram Kim, et al.
Published: (2020-09-01)

Immunohistochemical angiogenic biomarkers in hepatocellular carcinoma and cirrhosis: correlation with pathological features
by: Osmar Damasceno Ribeiro, et al.

Identification reproducible microbiota biomarkers for the diagnosis of cirrhosis and hepatocellular carcinoma
by: Huarong Zhang, et al.
Published: (2023-03-01)

Sulfatase 2 Along with Syndecan 1 and Glypican 3 Serum Levels are Associated with a Prognostic Value in Patients with Alcoholic Cirrhosis-Related Advanced Hepatocellular Carcinoma
by: Mouhoubi N, et al.
Published: (2022-12-01)

Expression and Correlation of MIF and ERK1/2 in Liver Cirrhosis and Hepatocellular Carcinoma Induced by Hepatitis B
by: Jia D, et al.
Published: (2023-04-01)

On-treatment risks of cirrhosis and hepatocellular carcinoma among a large cohort of predominantly non-Asian patients with non-cirrhotic chronic hepatitis B
by: Zeyuan Yang, et al.
Published: (2023-10-01)

Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression
by: Michelle Junyi He, et al.
Published: (2022-11-01)

Novel postoperative nomograms for predicting individual prognoses of hepatitis B-related hepatocellular carcinoma with cirrhosis
by: Liangliang Xu, et al.
Published: (2022-09-01)

Daily Aspirin Reduced the Incidence of Hepatocellular Carcinoma and Overall Mortality in Patients with Cirrhosis
by: Chern-Horng Lee, et al.
Published: (2023-05-01)

Multi-Omics Analyses Identify Signatures in Patients with Liver Cirrhosis and Hepatocellular Carcinoma
by: Ming-Wei Lai, et al.
Published: (2022-12-01)